Zung Jonathan B. 4
4 · Evelo Biosciences, Inc. · Filed Jan 29, 2021
Insider Transaction Report
Form 4
Zung Jonathan B.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-27+300,000→ 300,000 totalExercise: $16.65Exp: 2031-01-27→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This option will vest as to 25% of the total grant on January 4, 2022 and the remainder vesting thereafter in thirty-six (36) substantially equal monthly installments, subject to continued employment on such dates.